linagliptin
Inquiry
| Post Date: | Aug 27,2013 |
| Expiry Date: | Aug 27,2014 |
| Detailed Description: | Cas No. :668270-12-0 linagliptin CAS NO.668270-12-0,used as treatment of type Ⅱ Diabetes. |
| CAS Registry Number: | 668270-12-0 |
| Synonyms: | ;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-; |
| Molecular Formula: | C25H28N8O2 |
| Molecular Weight: | 472.5422 |
| Molecular Structure: | 
|
| Company: | Chengdu Yuyang High-Tech Development Co.,ltd [ China ] |
| Contact: | June.Xiao |
| Tel: | 86-28-61777709 |
| Fax: | 86-28-61777709 |
| Email: | yygk@yygk.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
